Capital World Investors Novo Nordisk A S Transaction History
Capital World Investors
- $592 Billion
- Q1 2025
A detailed history of Capital World Investors transactions in Novo Nordisk A S stock. As of the latest transaction made, Capital World Investors holds 207,770 shares of NVO stock, worth $14.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
207,770
Previous 4,446,019
95.33%
Holding current value
$14.5 Million
Previous $382 Million
96.23%
% of portfolio
0.0%
Previous 0.06%
Shares
29 transactions
Others Institutions Holding NVO
# of Institutions
1,761Shares Held
340MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.31 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.03 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$863 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$859 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$827 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $157B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...